Treating Acute Leukemias
in the Asia Pacific Region

A Worldwide Collaboration to Define and Refine the Most Effective Treatments in Leukemias

Overview

In recent years, progress in the understanding of acute leukemias has led to novel therapies that are rapidly changing treatment paradigms. Aptitude Health developed the Global Leukemia Academy to help physicians who treat acute leukemias bridge the gap between innovation and implementation for patient care.

Date and Location

Meeting postponed – new date will be released soon

Meeting Content

View the slides and watch the video of Day 1
Virtual Plenary Sessions

View the slides and watch the video of Day 2
Virtual Breakout: Adult Leukemia Patients

View the slides and watch the video of Day 2
Virtual Breakout: Pediatric ALL Patients

Faculty

Elias Jabbour

Elias Jabbour, MD

MD Anderson Cancer Center,
USA

Agenda

This 2-day interactive virtual meeting with global experts will focus on the management of patients with acute leukemia in various countries within the Asia Pacific region.

DAY 1: Follow presentations, join a debate on sequencing CD19-targeted strategies (systemic therapies vs CAR T), and engage with the faculty in panel discussions on optimal treatment and patient access, and regional challenges across the Asia Pacific region.

DAY 2: Join the pediatric or adult breakout session to learn about the treatment strategies for newly diagnosed and relapsed/refractory leukemia patients and attend the patient case-based panel discussions focusing on toxicity management.

Detailed agenda will follow in due course.

Day 1 – PLENARY SESSIONS Saturday, June 25

Chair: Elias Jabbour, MD

8.00 AM – 11.30 AM (Hong Kong UTC +8)
9.00 AM – 12.30 PM (Tokyo UTC +9)
10.00 AM – 1.30 PM (Sydney UTC +10)

Time (UTC +8) Topic Presenter
8.00 AM –
8.10 AM
Welcome and Meeting Overview Elias Jabbour
8.10 AM –
8.30 AM
What’s New in ALL? Recent Developments in Research and Management Hagop Kantarjian
8.30 AM –
8.50 AM
The Clinical Value of MRD in ALL: How MRD Can Guide the Use of Targeted Agents or Immunotherapy Jae Park
8.50 AM –
9.10 AM
Recent Insights in Genetic Variants in ALL: Ph+ and Ph-Like Elias Jabbour
9.10 AM –
9.30 AM
Current and Future Role of Transplantation in ALL Marcos De Lima
9.30 AM –
10.00 AM
Debate: How to Optimally Sequence CD19-Targeted Approaches in ALL
• Monoclonal antibodies and bispecifics first
• CAR T first
Moderator: Elias Jabbour
• Shaun Fleming
• Jae Park
10.00 AM –
10.10 AM
Break
10.10 AM –
10.30 AM
Changing Landscape of Treatment Options in Pediatric and AYA ALL tbc
10.30 AM –
10.55 AM
AYA Patient Case Discussion and Debate: The Evolving Concept of Transplantation in AYA Michael Osborn and Marcos De Lima
10.55 AM –
11.20 AM
Interactive Discussion: Regional Challenges of ALL Management Moderators: Shaun Fleming and Michael Osborn
11.20 AM –
11.30 AM
Session Close Elias Jabbour

Day 2 – BREAKOUT: ADULT ALL PATIENTS Sunday, June 26, 2022

Chair: Elias Jabbour

8.00 AM – 10.45 AM (Hong Kong UTC +8)
9.00 AM – 11.45 AM (Tokyo UTC +9)
10.00 AM – 12.45 PM (Sydney UTC +10)

Time (UTC +8) Topic Presenter
8.00 AM –
8.10 AM
Session Open Elias Jabbour
8.10 AM –
8.35 AM
Optimizing First-Line Therapy in Adult and Older ALL: Integration of Immunotherapy Into Frontline Regimens Elias Jabbour
8.35 AM –
9.00 AM
Current Treatment Options for Relapsed ALL in Adult and Elderly Patients Jae Park
9.00 AM –
9.40 AM
ALL Case-Based Panel Discussion Moderators: Shaun Fleming and Elias Jabbour
All Faculty
9.40 AM –
9.50 AM
Break
9.50 AM –
10.10 AM
Beyond the Horizon: New and Future Treatment Approaches for Adult and Older ALL Jae Park
10.10 AM –
10.35 AM
Interactive Discussion: Treatment Landscape Evolution Moderator: Elias Jabbour
All Faculty
10.35 AM –
10.45 AM
Session Close Elias Jabbour

Day 2 – BREAKOUT: PEDIATRIC ALL PATIENTS Sunday, June 26, 2022

Chair: tbc

8.00 AM – 10.45 AM (Hong Kong UTC +8)
9.00 AM – 11.45 AM (Tokyo UTC +9)
10.00 AM – 12.45 PM (Sydney UTC +10)

Time (UTC +8) Topic Presenter
8.00 AM –
8.10 AM
Session Open tbc
8.10 AM –
8.40 AM
Optimizing First-Line Therapy in Pediatric ALL: How to Balance Cure and Long-term Risks? tbc
8.40 AM –
9.00 AM
Optimal Management and Treatment Coordination of Long-term Toxicities in Pediatric ALL tbc
9.00 AM –
9.40 AM
ALL Case-Based Panel Discussion Moderators: Michael Osborn and tbc
9.40 AM –
9.50 AM
Break
9.50 AM –
10.15 AM
Current Treatment Options for Relapsed ALL in Children tbc
10.15 AM –
10.35 AM
ALL Case-Based Panel Discussion Moderators: Michael Osborn and tbc
10.35 AM –
10.45 AM
Session Close tbc